# Safety and Efficacy of Intensified Chemotherapy Regimens in Aggressive B-cell Lymphomas With MYC Rearrangement

> **NCT07663175** · — · ACTIVE_NOT_RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 500 (estimated)

## Conditions studied

- B-cell Lymphomas With MYC Rearrangement

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07663175
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07663175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07663175, "Safety and Efficacy of Intensified Chemotherapy Regimens in Aggressive B-cell Lymphomas With MYC Rearrangement". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07663175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*